GAITHERSBURG, Md., Sept. 23, 2021 /PRNewswire/ -- Novavax, Inc.
(Nasdaq: NVAX), a biotechnology company developing and
commercializing next-generation vaccines for serious infectious
diseases, today announced that it will participate in a fireside
chat at the 2021 Cantor Virtual Global Healthcare Conference.
Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
candidate, NVX-CoV2373, will be a topic of discussion.
Fireside chat
details:
|
|
Date:
|
Wednesday, September
29, 2021
|
|
Time:
|
8:40 – 9:10 a.m.
Eastern Daylight Time (EDT)
|
|
Moderator:
|
Charles C. Duncan,
Ph.D.
|
|
Novavax
participants:
|
Gregory M. Glenn,
M.D., President, Research and Development and John J. Trizzino,
Executive Vice President, Chief Commercial Officer and Chief
Business Officer
|
|
|
|
|
|
|
|
|
A replay of the recorded fireside session will be available
through the events page of the Company's website at ir.novavax.com
for 90 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) is a
biotechnology company that promotes improved health globally
through the discovery, development and commercialization of
innovative vaccines to prevent serious infectious diseases. The
company's proprietary recombinant technology platform combines the
power and speed of genetic engineering to efficiently produce
highly immunogenic nanoparticles designed to address urgent global
health needs. Novavax is conducting late-stage clinical trials for
NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus
that causes COVID-19. NanoFlu™, its quadrivalent influenza
nanoparticle vaccine, met all primary objectives in its pivotal
Phase 3 clinical trial in older adults and will be advanced for
regulatory submission. Both vaccine candidates incorporate Novavax'
proprietary saponin-based Matrix-M™ adjuvant to enhance the immune
response and stimulate high levels of neutralizing antibodies.
For more information, visit www.novavax.com and connect with us
on Twitter and LinkedIn.
Contacts:
Investors
Novavax, Inc.
Erika Schultz | 240-268-2022
ir@novavax.com
Solebury Trout
Alexandra Roy | 617-221-9197
aroy@soleburytrout.com
Media
Alison Chartan | 240-720-7804
Laura Keenan | 202-709-7521
media@novavax.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-fireside-chat-at-the-2021-cantor-virtual-global-healthcare-conference-301383813.html
SOURCE Novavax, Inc.